-The Hindu Switching to renewable energy sources in the country's midday meal programme will save millions of rupees. But only a few kitchens are doing anything about it, says the author. This is a story of facts and figures and sheer size. Of an auditorium-sized room dense with hot steam from cooking. Of seven tonnes of cooked rice and four tanker-loads of steaming sambar that needed 70 pairs of hands for cutting...
More »SEARCH RESULT
Court upholds Soliga tribe’s community forest rights-Aparna Pallavi
-Down to Earth Orders forest department to restore honey seized during raid The court of judicial magistrate of Chamrajnagar in Karnataka has upheld the rights of Soliga tribal people to harvest and sell forest produce independent of the forest department. On May 24, the court ordered Punjanur range forest officer to return 1,100 kg of honey seized from the Hosepodu gram sabha, located within the Biligiri Rangaswami Temple (BRT) tiger reserve, during...
More »Indian pharma's generic challenge-DG Shah
-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...
More »USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman
-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...
More »Ranbaxy's dark chapter-Bhupesh Bhandari
-The Business Standard Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years The Ranbaxy affair is one of the darkest chapters of India's business history. The company has admitted it fudged data so that it could launch its products in the United States. It has now paid $500 million as a penalty to settle the case. It is worse than Ramalinga...
More »